Skip to main content
Terug
SVRA logo

Savara Inc.

Datakwaliteit: 100%
SVRA
NASDAQ Healthcare Biotechnology
€ 5,08
▲ € 0,12 (2,42%)
Marktkapitalisatie: 1,04B
Dagbereik
€ 4,94 € 5,19
52-Weeksbereik
€ 1,89 € 7,01
Volume
1.952.867
50D / 200D Gem.
€ 5,61 / € 4,23
Vorige Slotkoers
€ 4,96

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E -8,8 0,4
P/B 5,1 2,9
ROE % -63,5 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,2 0,2

Belangrijkste Punten

Debt/Equity of 0,15 — conservative balance sheet
Negative free cash flow of -101,06M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-63,45%
ROIC-39,76%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,15
Current Ratio11,85
Interest Coverage0,00

Waardering

P/E Ratio
-8,75
P/B Ratio5,12
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -118,84M
ROE -63,45% ROA -46,89%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -101,06M
ROIC -39,76% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,15 Current Ratio 11,85
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -8,75 P/B Ratio 5,12
P/S Ratio N/A PEG Ratio -1,08
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 1,04B Enterprise Value 1,04B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -118,84M -95,88M -54,70M -38,15M -43,01M
EPS (Diluted) -0,53 -0,48 -0,33 -0,25 -0,32
Gross Profit -245.000,0 -78,03M -44,26M -27,88M -28,99M
Operating Income -123,55M -103,20M -60,01M -38,84M -41,48M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 253,44M 212,88M 177,56M 139,78M 176,60M
Total Liabilities 50,30M 41,43M 37,19M 32,00M 32,10M
Shareholders' Equity 203,13M 171,45M 140,37M 107,78M 144,50M
Total Debt 29,91M 26,74M 26,49M 26,14M 25,79M
Cash & Equivalents 33,18M 15,13M 26,59M 52,10M 34,01M
Current Assets 241,62M 202,14M 165,95M 128,95M 165,00M
Current Liabilities 20,40M 14,72M 10,60M 5,87M 14,66M